Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prognostication of survival using cardiac troponins and N- terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing.

Similar presentations


Presentation on theme: "Prognostication of survival using cardiac troponins and N- terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing."— Presentation transcript:

1 Prognostication of survival using cardiac troponins and N- terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation by Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, Martha Q. Lacy, Mary F. Burritt, Terry M. Therneau, Joseph P. McConnell, Mark R. Litzow, Dennis A. Gastineau, Ayalew Tefferi, David J. Inwards, Ivana N. Micallef, Stephen M. Ansell, Luis F. Porrata, Michelle A. Elliott, William J. Hogan, S. Vincent Rajkumar, Rafael Fonseca, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Steven R. Zeldenrust, Denise S. Snow, Susan R. Hayman, Christopher G. A. McGregor, and Allan S. Jaffe Blood Volume 104(6):1881-1887 September 15, 2004 ©2004 by American Society of Hematology

2 Survival according to circulating cardiac biomarkers. Angela Dispenzieri et al. Blood 2004;104:1881-1887 ©2004 by American Society of Hematology

3 Survival according to risk scores or stage. Angela Dispenzieri et al. Blood 2004;104:1881-1887 ©2004 by American Society of Hematology


Download ppt "Prognostication of survival using cardiac troponins and N- terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing."

Similar presentations


Ads by Google